The purpose of this study is to determine whether a top-down treatment approach, prescribing
infliximab and azathioprine at diagnose, yields better outcome in comparison to the usual
step-up treatment approach, starting with prednison and azathioprine, in moderate-to-severe
pediatric Crohn's disease (CD) patients.
Phase:
Phase 4
Details
Lead Sponsor:
Erasmus Medical Center
Collaborators:
Universitair Ziekenhuis Brussel University of Roma La Sapienza